Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Enters Heart Failure Market

Jun 20, 2017 at 3:20 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment